Our Comprehensive
Business Models
At Solis, innovation is at the heart of everything we do-both in our products and the way we operate.
We are dedicated to continuous improvement, adaptability, and staying ahead of the curve to ensure our approach to the pharmaceutical industry remains as forward-thinking as the therapies we deliver.
Our operational models include:
Joint Ventures (JV)
At Solis, we collaborate with leading pharmaceutical companies to pool resources and expertise, creating powerful synergies that drive innovation and foster growth. These strategic alliances allow us to expand our capabilities and accelerate the development of breakthrough therapies.
In-licensing with Marketing Authorization
We strategically acquire rights to innovative drug candidates from other companies, enriching our portfolio with cutting-edge treatments. This approach enables us to bring promising new therapies to market, addressing unmet medical needs and enhancing patient outcomes.
Development and Co-Development
Our collaborative approach to product development empowers us to share knowledge, minimize risks, and streamline the path to market for new therapies. By partnering with key industry players, we ensure faster, more efficient development of life-changing medications.
